Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI
· Real-Time Price · USD
14.59
0.04 (0.27%)
At close: Jun 16, 2025, 3:59 PM
15.29
4.83%
After-hours: Jun 16, 2025, 05:54 PM EDT
0.27% (1D)
| Bid | 14.43 |
| Market Cap | 2.12B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -453.94M |
| EPS (ttm) | -2.62 |
| PE Ratio (ttm) | -5.57 |
| Forward PE | -5.32 |
| Analyst | Buy |
| Ask | 15.97 |
| Volume | 925,756 |
| Avg. Volume (20D) | 1,504,750 |
| Open | 14.60 |
| Previous Close | 14.55 |
| Day's Range | 14.31 - 14.62 |
| 52-Week Range | 10.57 - 33.33 |
| Beta | 1.33 |
About DNLI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DNLI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DNLI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+11.8%
Denali Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
3 months ago
-8.21%
Denali Therapeutics shares are trading lower after Oppenheimer cut its price target on the stock from $50 to $42.
